Premium
Use‐dependent effects of pirmenol on and conduction in guinea‐pig ventricular myocardium
Author(s) -
Hasegawa Junichi,
Hirai Shozo,
Noguchi Noriyasu,
Hisatome Ichiro,
Kotake Hiroshi,
Mashiba Hiroto
Publication year - 1990
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1990.tb13012.x
Subject(s) - nerve conduction velocity , medicine , electrophysiology , cardiology , endocrinology
1 The use‐dependent effects of pirmenol, a new antiarrhythmic drug, on the maximal rate of rise of the action potential, conduction velocity, and their corresponding recovery kinetics were studied in isolated papillary muscles of guinea‐pig. Standard microelectrode techniques were used to monitor the conduction and action potential characteristics of the muscles. 2 Pirmenol decreased and the overshoot of action potentials in a dose‐dependent fashion. Also, doses of pirmenol greater than 1 m m abolished the generation of action potentials. Low concentrations of pirmenol (3 and 10 μ m ) prolonged the action potential duration, while concentrations greater than 0.1 m m shortened it markedly. 3 The resting block of in the presence of 10 and 30 μ m pirmenol was 9.48 ± 3.12 and 20.36 ± 3.61%, and that of conduction velocity 2.87 ± 1.52 and 6.58 ± 2.09%, respectively. 4 The degree of use‐dependent block induced by 10 and 30 μ m pirmenol during 0.2, 1, 2 and 3 Hz stimulations was dose‐ and rate‐dependent. 5 In the presence of 30 μ m pirmenol, mean values of time constants for the onset of the use‐dependent inhibition of and conduction velocity during a 2 Hz stimulation were 1.32 ± 0.15 and 1.28 ± 0.09 s, respectively. The recovery time constants averaged 15.83 ± 2.14 (for ) and 27.80 ± 8.74 (for conduction velocity) s in the presence of 30 μ m pirmenol. 6 These results showed that the characteristics of the use‐dependent inhibition of and conduction velocity induced by pirmenol are similar to those of slow kinetic drugs such as disopyramide rather than of fast ones.